Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
07/2014
07/15/2014US8779143 Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form
07/10/2014US20140194349 HIV Protease Inhibiting Compounds
07/08/2014US8772492 Substituted isoquinoline and isoquinolinone derivatives
07/08/2014CA2650009C Il-8 receptor antagonists
07/08/2014CA2635850C Heterocyclic janus kinase 3 inhibitors
07/03/2014WO2014102829A1 Crystalline atropine sulfate
07/03/2014WO2014102589A1 Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
07/03/2014US20140187544 Oxime-substituted-quinoxaline-type piperidine compounds and uses thereof
07/03/2014US20140187531 Apoptosis promoters
07/02/2014CN102718760B 一种曲司氯铵合成工艺 One kind of trospium chloride synthesis process
06/2014
06/25/2014CN103889951A 唑类衍生物 Azole derivative
06/25/2014CN103880837A 一种西托溴铵的合成方法 Synthesis method Esposito bromide
06/19/2014WO2014092100A1 Heterocyclic compound
06/19/2014US20140171404 Autotaxin inhibitors
06/18/2014CN103864777A Simple synthesis method of scopolamine butylbromide
06/18/2014CN102007124B Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
06/18/2014CN101506140B Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
06/12/2014US20140163063 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
06/12/2014US20140163062 Remedy for psychoneurotic diseases
06/12/2014US20140162999 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof
06/12/2014US20140162983 Compositions and Methods for the Production of Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity
06/11/2014EP2739622A1 Precursor compounds for the radiosynthesis of [18f]norchloro-fluorohomoepibatidine
06/11/2014CN101595100B Heterocyclic-substituted piperidine as orl-1 ligands
06/10/2014US8748457 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155408 Pyruvate kinase activators for use in therapy
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/03/2014CA2568804C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
05/2014
05/27/2014CA2789645C Cyclic amine compound and acaricide
05/27/2014CA2631949C Micronization method for preparing virtually anhydrous tiotropium bromide monohydrate
05/27/2014CA2603654C Crystalline hydrochloride salt of a quinolinone-carboxamide compound or a solvate thereof
05/22/2014WO2014078611A1 Dihydropyrazole gpr40 modulators
05/14/2014CN103787954A 一类氟取代的环状胺类化合物及其制备方法、药物组合物和用途 A class of fluorine-substituted cyclic amine compounds and their preparation, pharmaceutical compositions and uses
05/14/2014CN101484424B 治疗化合物 Therapeutic compounds
05/08/2014WO2014067499A1 Stabilization of tiotropium solvates
05/07/2014CN103781784A 用于辐射合成[<sup>18</sup>F]去氯-氟占据最高分子轨道地棘蛙素的前驱体化合物 Fluorine precursor compounds occupy the highest molecular orbital epibatidine of - for radiation synthesis [<sup> 18 </ sup> F] to chlorine
05/07/2014CN103772379A 一种曲司氯铵关键中间体的制备方法 Preparation method of trospium chloride key intermediates
05/07/2014CN101648950B 噻托铵盐、其医药制剂及其用途 Tiotropium salts, their pharmaceutical formulations and their use
05/06/2014CA2573373C Method for producing tiotropium salts and silicon derivatives as intermediates
05/01/2014WO2014063587A1 Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof
04/2014
04/29/2014CA2661741C N-pyridylpiperidine compound, method for producing the same, and pest control agent
04/23/2014EP2721008A1 Hydroxy substituted isoquinolinone derivatives
04/22/2014US8703165 Spiro fused 1-amino-piperdine pyrrolidine dione derivatives with pesticidal activity
04/22/2014CA2637214C Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 receptor agonist compounds
04/22/2014CA2620418C Benztropine compounds and uses thereof
04/17/2014WO2014056083A1 Kinase inhibitors and method of treating cancer with same
04/16/2014EP2718280A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
04/10/2014WO2014054053A1 Spirocyclic compounds, compositions and medicinal applications thereof
04/03/2014US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
04/03/2014US20140093518 Chemically Programmed Vaccination
04/01/2014US8686148 Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
03/2014
03/27/2014WO2014045031A1 Bicyclic aza compounds as muscarinic m1 receptor agonists
03/27/2014WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
03/27/2014US20140088086 Compounds and methods for treatment of hypertension
03/25/2014US8680115 Tetrahydroquinoline analogues as muscarinic agonists
03/20/2014WO2014042605A1 New tiotropium bromide crystalline form
03/20/2014US20140080856 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
03/20/2014US20140080855 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
03/20/2014US20140079634 Labeled pe2i formulation and method
03/19/2014CN103649084A 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/13/2014US20140073635 Substituted Imidazopyridinyl-Aminopyridine Compounds
03/12/2014EP2705838A1 Tiotropium preparations
03/12/2014CN203469997U Device for preparing key intermediate of trospium chloride
03/11/2014US8669367 Method for producing 2-azaadamantane
03/05/2014EP2702053A2 Novel rock inhibitors
03/04/2014US8664242 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
02/2014
02/27/2014US20140057935 Novel forms of tiotropium bromide and processes for preparation thereof
02/26/2014EP2699570A1 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
02/25/2014US8658796 Complexes of ruthenium, method of production thereof and use thereof as (pre)catalysts of the metathesis reaction
02/25/2014US8658671 Crystalline form of a quinolinone-carboxamide compound
02/25/2014US8658654 Receptor-type kinase modulators and methods of use
02/20/2014WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
02/20/2014US20140051687 Substituted indole compounds having nos inhibitory activity
02/20/2014US20140051679 Kinase inhibitors and method of treating cancer with same
02/20/2014US20140051676 Triazine-oxadiazoles
02/18/2014US8653145 Method for alleviating climacteric symptoms
02/13/2014US20140045817 Triazolopyridine compounds as pim kinase inhibitors
02/12/2014CN101573354B Substituted isoquinolines and their use as Rho-kinase inhibitors
02/06/2014US20140038980 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
02/05/2014CN103562198A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
02/04/2014US8642764 Julolidine conjugates and methods for their preparation and use
02/04/2014CA2491191C Receptor-type kinase modulators and methods of use
01/2014
01/30/2014US20140031349 Inhibitors of the renal outer medullary potassium channel
01/30/2014US20140030191 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
01/29/2014EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
01/29/2014CN102267993B Polyhydroxy desmethyl tropane compounds and preparation method and use thereof
01/23/2014WO2014014962A1 5ht3 receptor antagonists
01/23/2014WO2014014951A1 5-ht3 receptor antagonists
01/23/2014US20140024643 Bridged heterocyclic compounds and methods of use
01/22/2014CN103534249A Novel rock inhibitors
01/21/2014US8633218 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
01/16/2014WO2014009447A1 ARYL SULTAM DERIVATIVES AS RORc MODULATORS
01/16/2014US20140018317 Targeted nitroxide agents
01/16/2014CA2876449A1 Aryl sultam derivatives as rorc modulators
01/15/2014EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
01/14/2014US8628759 Soft anticholinergic esters
01/09/2014WO2014007144A1 Method for producing alicyclic n-oxyl compound
01/09/2014WO2014005274A1 Multi-substituted 8-nitrogen heterocyclic ring [3.2.1] octane compound
01/08/2014EP2681213A1 Anhydrous crystalline form of tiotropium bromide
1 2 3 4 5 6 7 8 9 10 11 12 ... 53